Home About us Articles Multimedia Search Instructions Login 
IF 2017: 1.596 (® Clarivate Analytics)
Total Cites: 7606
Q2 in Medicine, General & Internal
Follow Us
Follow Us
  • Users Online: 3867
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Inhibition of Ubiquitin-specific Peptidase 8 Suppresses Adrenocorticotropic Hormone Production and Tumorous Corticotroph Cell Growth in AtT20 Cells

Jian Fang-Fang, Li Yun-Feng, Chen Yu-Fan, Jiang Hong, Chen Xiao, Zheng Li-Li, Zhao Yao, Wang Wei-Qing, Ning Guang, Bian Liu-Guan, Sun Qing-Fang

Year : 2016| Volume: 129| Issue : 17 | Page no: 2102-2108

   This article has been cited by
1 New Molecular Targets for Treatment of Cushing’s Disease
Elizabeth Foulkes,John Newell-Price
Endocrinology and Metabolism Clinics of North America. 2018; 47(2): 367
[Pubmed]  [Google Scholar] [DOI]
2 New and emerging drug therapies for Cushing’s disease
Sylvère Störmann,Jochen Schopohl
Expert Opinion on Pharmacotherapy. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer
Wenyu Hu,Haiyan Wei,Keming Li,Pei Li,Jiamao Lin,Rui Feng
Cell Proliferation. 2017; : e12343
[Pubmed]  [Google Scholar] [DOI]
4 Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
Anat Ben-Shlomo,Odelia Cooper
Current Opinion in Endocrinology & Diabetes and Obesity. 2017; 24(4): 301
[Pubmed]  [Google Scholar] [DOI]
5 Genetics of Cushingæs disease
Adriana Albani,Marily Theodoropoulou,Martin Reincke
Clinical Endocrinology. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article